免疫检查点阻断通过扩增效应 CD8⁺ T 细胞克隆增强淋巴细胞清除性化疗诱导的抗肿瘤免疫
Immune Checkpoint Blockade Augments Lymphodepleting Chemotherapy-Induced Antitumor Immunity by Expanding Effector CD8+ T-cell Clones.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
转移性黑色素瘤对检查点抑制剂治疗的应答与原发皮肤黑色素瘤活检中 TIL（肿瘤浸润淋巴细胞）分类之间的关联
英文原题：Association Between Metastatic Melanoma Response to Checkpoint Inhibitor Therapy and Tumor-Infiltrating Lymphocyte Classification on Primary Cutaneous Melanoma Biopsies.
查看英文原题
Association Between Metastatic Melanoma Response to Checkpoint Inhibitor Therapy and Tumor-Infiltrating Lymphocyte Classification on Primary Cutaneous Melanoma Biopsies.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
中文摘要
本队列研究探讨了接受检查点抑制剂治疗的转移性原发性皮肤黑色素瘤患者中，TIL（肿瘤浸润淋巴细胞）分类与疾病进展之间的关联。
展开英文摘要原文
This cohort study examines the association between tumor-infiltrating lymphocyte classification and disease progression among patients with metastatic primary cutaneous melanoma receiving checkpoint inhibitor therapy.
论文信息
- 作者
- Stephens MR、Aderbigbe O、Xu W、Karakousis GC、Ming ME、Chu EY
- 第一作者单位
- Department of Dermatology, Harvard School of Medicine, Harvard University, Boston, Massachusetts.United States
- 通讯作者单位
- Perelman School of Medicine, Department of Dermatology, University of Pennsylvania, Philadelphia.United States
- 期刊
- JAMA dermatology2023 Feb 1
- 原文标识
- PubMed 36477253 · DOI 10.1001/jamadermatol.2022.4959
在 PubMed 查看 → 出版商原文（DOI） 全文 PDF（PMC）· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →